日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-Acting Cabotegravir/Rilpivirine, Lenacapavir, and Ibalizumab Use Among Persons With HIV-1 Viremia at a Ryan White-Funded Clinic in the Urban US South

美国南部城市一家由瑞安·怀特基金会资助的诊所中,HIV-1病毒血症患者使用长效卡博特韦/利匹韦林、莱那卡帕韦和伊巴利珠单抗的情况

Colasanti, Jonathan A; Aldredge, Amalia; Niles-Carnes, Larisa V; Ochieng, Eudiah; Pareek, Priyasha; Robinson, Vickie; Anderson, Erica; Castaneda, Mary; Spralling, Hilary; Smith, Bradley L; Sumitani, Jeri; Paul Leue, Eric; Moran, Caitlin A; Lora, Meredith; Armstrong, Wendy S; Collins, Lauren F